This study aims to isolate and characterize EVs released by PC9 lung cancer cells (harboring an EGFR deletion mutation in exon 19 (2235-2257C)) and A549 lung cancer cells (wild-type EGFR). This evidence concerns the gene EGFR and lung cancer.